Mathieu Bangert

3.2k total citations · 1 hit paper
46 papers, 1.3k citations indexed

About

Mathieu Bangert is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mathieu Bangert has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 18 papers in Pulmonary and Respiratory Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mathieu Bangert's work include Respiratory viral infections research (21 papers), Pneumonia and Respiratory Infections (20 papers) and Tracheal and airway disorders (8 papers). Mathieu Bangert is often cited by papers focused on Respiratory viral infections research (21 papers), Pneumonia and Respiratory Infections (20 papers) and Tracheal and airway disorders (8 papers). Mathieu Bangert collaborates with scholars based in United Kingdom, France and Switzerland. Mathieu Bangert's co-authors include Christopher Fitzpatrick, Aras Kadioglu, Steve W. Lindsay, Dirk Engels, David Molyneux, Andrea M. Collins, Daniel R. Neill, Stephen B. Gordon, Daniela M. Ferreira and Laura Bricio-Moreno and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mathieu Bangert

45 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants

2023 175 citations Simon B. Drysdale, Katrina Cathie et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathieu Bangert United Kingdom	19	749	241	218	217	188	46	1.3k
Laura Sangaré United States	17	258 0.3×	233 1.0×	184 0.8×	78 0.4×	185 1.0×	33	1.1k
Heinz‐Josef Schmitt Germany	23	1.2k 1.6×	177 0.7×	561 2.6×	136 0.6×	163 0.9×	42	1.7k
Annette Jepson United Kingdom	24	479 0.6×	574 2.4×	310 1.4×	263 1.2×	118 0.6×	38	1.7k
Grant Mackenzie Gambia	20	540 0.7×	147 0.6×	162 0.7×	113 0.5×	32 0.2×	83	1.3k
Robert J. Leggiadro United States	20	944 1.3×	256 1.1×	496 2.3×	136 0.6×	50 0.3×	92	1.5k
Kyle Knox United Kingdom	18	539 0.7×	123 0.5×	412 1.9×	112 0.5×	48 0.3×	25	1.3k
Rajinder Bajwa United States	14	365 0.5×	91 0.4×	238 1.1×	99 0.5×	32 0.2×	68	1.4k
Maria Koliou Cyprus	20	493 0.7×	631 2.6×	626 2.9×	79 0.4×	105 0.6×	49	1.4k
Hasan Tezer Türkiye	16	327 0.4×	173 0.7×	414 1.9×	96 0.4×	47 0.3×	137	1.1k
Mary Bavaro United States	20	635 0.8×	125 0.5×	522 2.4×	119 0.5×	27 0.1×	35	1.3k

Countries citing papers authored by Mathieu Bangert

Since Specialization

Citations

This map shows the geographic impact of Mathieu Bangert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Bangert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Bangert more than expected).

Fields of papers citing papers by Mathieu Bangert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Bangert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Bangert. The network helps show where Mathieu Bangert may publish in the future.

Co-authorship network of co-authors of Mathieu Bangert

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Bangert. A scholar is included among the top collaborators of Mathieu Bangert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Bangert. Mathieu Bangert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wetzke, Martin, Matthias Lange, Cordula Koerner‐Rettberg, et al.. (2025). RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021–2023. Infection. 53(5). 1715–1723. 2 indexed citations

Hoor, Gill A. ten, et al.. (2025). Promoting influenza vaccination behavior among healthcare workers in the gulf cooperation council countries; Lessons from the [2023 SANOFI Round Table Meeting, September 17th, 2023, Valencia, Spain]. Vaccine X. 23. 100617–100617.

Bangert, Mathieu, et al.. (2024). Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review. Influenza and Other Respiratory Viruses. 18(8). e13344–e13344. 14 indexed citations

Bangert, Mathieu, et al.. (2024). Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review. BMC Infectious Diseases. 24(1). 844–844. 8 indexed citations

Staadegaard, Lisa, Michel Dückers, Jojanneke van Summeren, et al.. (2024). Determining the timing of respiratory syncytial virus (RSV) epidemics: a systematic review, 2016 to 2021; method categorisation and identification of influencing factors. Eurosurveillance. 29(5). 6 indexed citations

Caini, Saverio, Jean‐Sébastien Casalegno, Ana Paula Rodrigues, et al.. (2024). Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study. Journal of Infection. 88(5). 106154–106154. 2 indexed citations

Hagenaars, Saskia P., et al.. (2024). Respiratory Syncytial Virus Hospital Admission Rates and Patients’ Characteristics Before the Age of 2 Years in England, 2015–2019. The Pediatric Infectious Disease Journal. 43(9). 909–915. 1 indexed citations

Barbieri, Elisa, Luigi Cantarutti, Lorenzo Bertizzolo, et al.. (2023). Assessing the burden of bronchiolitis and lower respiratory tract infections in children ≤24 months of age in Italy, 2012–2019. Frontiers in Pediatrics. 11. 1143735–1143735. 14 indexed citations

Kramer, Rolf, et al.. (2023). Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019–2022. Influenza and Other Respiratory Viruses. 17(11). e13211–e13211. 11 indexed citations

10.

Martinón‐Torres, Federico, et al.. (2023). Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015–2018. BMC Infectious Diseases. 23(1). 385–385. 32 indexed citations

11.

Drysdale, Simon B., Katrina Cathie, Florence Flamein, et al.. (2023). Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. New England Journal of Medicine. 389(26). 2425–2435. 175 indexed citations breakdown →

12.

Bandeira, Teresa, H. de Souza Lopes, Catarina Gomes, et al.. (2022). Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015–2018. Influenza and Other Respiratory Viruses. 17(1). e13066–e13066. 18 indexed citations

13.

Mupfasoni, Denise, Mathieu Bangert, Alexei Mikhailov, Chiara Marocco, & Antonio Montresor. (2019). Sustained preventive chemotherapy for soil-transmitted helminthiases leads to reduction in prevalence and anthelminthic tablets required. Infectious Diseases of Poverty. 8(1). 82–82. 13 indexed citations

14.

Bangert, Mathieu, et al.. (2019). Provision of deworming intervention to pregnant women by antenatal services in countries endemic for soil-transmitted helminthiasis. PLoS neglected tropical diseases. 13(5). e0007406–e0007406. 17 indexed citations

15.

Fitzpatrick, Christopher, Mathieu Bangert, Pamela Sabina Mbabazi, et al.. (2018). Monitoring equity in universal health coverage with essential services for neglected tropical diseases: an analysis of data reported for five diseases in 123 countries over 9 years. The Lancet Global Health. 6(9). e980–e988. 18 indexed citations

16.

Bangert, Mathieu, David Molyneux, Steve W. Lindsay, Christopher Fitzpatrick, & Dirk Engels. (2017). The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals. Infectious Diseases of Poverty. 6(1). 73–73. 131 indexed citations

17.

Fitzpatrick, Christopher, Alex Haines, Mathieu Bangert, et al.. (2017). An economic evaluation of vector control in the age of a dengue vaccine. PLoS neglected tropical diseases. 11(8). e0005785–e0005785. 53 indexed citations

18.

Wright, Adam, Mathieu Bangert, Jenna F. Gritzfeld, et al.. (2013). Experimental Human Pneumococcal Carriage Augments IL-17A-dependent T-cell Defence of the Lung. PLoS Pathogens. 9(3). e1003274–e1003274. 69 indexed citations

19.

Ferreira, Daniela M., Daniel R. Neill, Mathieu Bangert, et al.. (2013). Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults. American Journal of Respiratory and Critical Care Medicine. 187(8). 855–864. 105 indexed citations

20.

Bangert, Mathieu, Laura Bricio-Moreno, Gowrisankar Rajam, et al.. (2012). P4-Mediated Antibody Therapy in an Acute Model of Invasive Pneumococcal Disease. The Journal of Infectious Diseases. 205(9). 1399–1407. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact